ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Butyrolactone I attenuates inflammation in murine NASH by inhibiting the NF-KB signaling pathway

Tian-qi, Chen; Yan-fang, Deng; Yan-yan, Wang*; Yong-hui, Zhang*华中科技大学
Biochemical and Biophysical Research Communications2022-10-20DOI: 10.1016/j.bbrc.2022.07.050
1被引10阅读
引用收藏
分享

摘要

Nonalcoholic steatohepatitis (NASH) is the development of non-alcoholic fatty liver disease (NAFLD) and a key element in the exacerbation of NAFLD. Since there are currently no drugs approved by the U.S. Food and Drug Administration to treat this disease, the search for treatments that can be translated into clinical use is urgent. Butyrolactone I (BLI), isolated from Aspergillus terreus, is an active compound possessing multiple biological activities. However, the effects of BLI on NASH have never been reported. In this study, RAW264.7 cells stimulated by lipopolysaccharide (LPS) were applied to study the antiinflammatory effect and the underlying mechanisms of BLI in vitro. Following this, mice fed with high-fat and -fructose diet (HFFD) were used to explore the alleviation of NASH by BLI in vivo. We found that BLI attenuated inflammation in LPS-induced RAW264.7 cells by inhibiting the NF-KB signaling pathway and downregulating the expression of iNOS and COX-2. Moreover, results of experiments in vivo demonstrated that BLI reduced serum transaminase levels, decreased hepatic fat accumulation, inhibited inflammation, suppressed oxidative stress, and ameliorated liver fibrosis. For the first time, we investigated the role of BLI in the treatment of murine NASH. We found that BLI alleviates NASH partly by inhibiting the NF-KB pathway of signaling. Given its hepatoprotective effects and non-toxic properties, BLI can be a novel and effective drug for NASH patients.

学科与关键词

关键词
Nonalcoholic steatohepatitisButyrolactone IInflammationNF-KB signaling pathway
相关
加载中…
  • Kinsenoside alleviates inflammation and fibrosis in experimental NASH mice by suppressing the NF-ΚB/NLRP3 signaling pathway
    Deng, Yan-fang; Xu, Qian-qian; Chen, Tian-qi; Ming, Jia-xiong; Wang, Ya-fen; Mao, Li-na; Zhou, Jia-jun; Sun, Wei-guang*; Zhou, Qun*; Ren, Hong*; Zhang, Yong-hui*PHYTOMEDICINE, 2022, 104: 154241.被引 13
  • Neferine ameliorates nonalcoholic steatohepatitis through regulating AMPK pathway
    Wang, Ming-Yue; Zhang, Shao-Shi; An, Meng - Fei; Xia, Yue-fei; Fan, Mao-Si; Sun, Ze-Rui; Zhang, Li-Juan; Zhao, Yun-Li*; Sheng, Jun*; Wang, Xuan-Jun*PHYTOMEDICINE, 2023, 114: 154798.
  • Salvianolic acid B ameliorates non-alcoholic fatty liver disease by inhibiting hepatic lipid accumulation and NLRP3 inflammasome in ob/ob mice
    Meng, Ling-Cui; Zheng, Jia-Yi; Qiu, Yu-Hui; Zheng, Li; Zheng, Jue-Yan; Liu, Yu-Qing; Miao, Xiao-Lu*; Lu, Xin-Yi*International Immunopharmacology, 2022, 111: 109099.被引 9
查看全部 →

发表信息

论文状态
公开发表
期刊
Biochemical and Biophysical Research Communications
发表日期
2022-10-20
卷期
第 626 卷
页码
167-174
DOI
10.1016/j.bbrc.2022.07.050
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82003633]; Hubei Provincial Science and Technology Major Special Funds [2020ACA019, 2021ACA004]

作者

  • T

    Tian-qi, Chen (第一作者)

    china three gorges univ

  • Y

    Yan-fang, Deng

    huazhong univ sci & technol

查看全部 4 位作者收起作者
  • Y

    Yan-yan, Wang (通讯)

    china three gorges univ

  • Y

    Yong-hui, Zhang (通讯)

    huazhong univ sci & technol

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417